302 related articles for article (PubMed ID: 36421349)
1. Focused Delivery of Chemotherapy to Augment Surgical Management of Brain Tumors.
Mehkri Y; Woodford S; Pierre K; Dagra A; Hernandez J; Reza Hosseini Siyanaki M; Azab M; Lucke-Wold B
Curr Oncol; 2022 Nov; 29(11):8846-8861. PubMed ID: 36421349
[TBL] [Abstract][Full Text] [Related]
2. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
3. Surgical Management of Brain Tumors with Focused Ultrasound.
Mehkri Y; Pierre K; Woodford SJ; Davidson CG; Urhie O; Sriram S; Hernandez J; Hanna C; Lucke-Wold B
Curr Oncol; 2023 May; 30(5):4990-5002. PubMed ID: 37232835
[TBL] [Abstract][Full Text] [Related]
4. Overview of Current Drug Delivery Methods Across the Blood-Brain Barrier for the Treatment of Primary Brain Tumors.
Haumann R; Videira JC; Kaspers GJL; van Vuurden DG; Hulleman E
CNS Drugs; 2020 Nov; 34(11):1121-1131. PubMed ID: 32965590
[TBL] [Abstract][Full Text] [Related]
5. Enhancing glioblastoma treatment using cisplatin-gold-nanoparticle conjugates and targeted delivery with magnetic resonance-guided focused ultrasound.
Coluccia D; Figueiredo CA; Wu MY; Riemenschneider AN; Diaz R; Luck A; Smith C; Das S; Ackerley C; O'Reilly M; Hynynen K; Rutka JT
Nanomedicine; 2018 Jun; 14(4):1137-1148. PubMed ID: 29471172
[TBL] [Abstract][Full Text] [Related]
6. Focused ultrasound delivery of Raman nanoparticles across the blood-brain barrier: potential for targeting experimental brain tumors.
Diaz RJ; McVeigh PZ; O'Reilly MA; Burrell K; Bebenek M; Smith C; Etame AB; Zadeh G; Hynynen K; Wilson BC; Rutka JT
Nanomedicine; 2014 Jul; 10(5):1075-87. PubMed ID: 24374363
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery.
Arsiwala TA; Sprowls SA; Blethen KE; Adkins CE; Saralkar PA; Fladeland RA; Pentz W; Gabriele A; Kielkowski B; Mehta RI; Wang P; Carpenter JS; Ranjan M; Najib U; Rezai AR; Lockman PR
Neoplasia; 2021 Jul; 23(7):676-691. PubMed ID: 34139452
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood-tumor barrier disruption.
Park J; Aryal M; Vykhodtseva N; Zhang YZ; McDannold N
J Control Release; 2017 Mar; 250():77-85. PubMed ID: 27742444
[TBL] [Abstract][Full Text] [Related]
9. Cell Mediated Photothermal Therapy of Brain Tumors.
Hirschberg H; Madsen SJ
J Neuroimmune Pharmacol; 2017 Mar; 12(1):99-106. PubMed ID: 27289473
[TBL] [Abstract][Full Text] [Related]
10. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
[TBL] [Abstract][Full Text] [Related]
11. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
Liu HL; Yang HW; Hua MY; Wei KC
Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial therapeutic strategies for enhanced delivery of therapeutics to brain cancer cells through nanocarriers: current trends and future perspectives.
Wang X; Wu C; Liu S; Peng D
Drug Deliv; 2022 Dec; 29(1):1370-1383. PubMed ID: 35532094
[TBL] [Abstract][Full Text] [Related]
13. Targeted Delivery of DNA-Au Nanoparticles across the Blood-Brain Barrier Using Focused Ultrasound.
Chan TG; Morse SV; Copping MJ; Choi JJ; Vilar R
ChemMedChem; 2018 Jul; 13(13):1311-1314. PubMed ID: 29742322
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies to improve drug delivery across the blood-brain barrier.
Azad TD; Pan J; Connolly ID; Remington A; Wilson CM; Grant GA
Neurosurg Focus; 2015 Mar; 38(3):E9. PubMed ID: 25727231
[TBL] [Abstract][Full Text] [Related]
15. Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.
Wang Z; Sun H; Yakisich JS
Anticancer Agents Med Chem; 2014; 14(8):1085-93. PubMed ID: 23092271
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
[TBL] [Abstract][Full Text] [Related]
17. Targeting Nanomedicine to Brain Tumors: Latest Progress and Achievements.
Van't Root M; Lowik C; Mezzanotte L
Curr Pharm Des; 2017; 23(13):1953-1962. PubMed ID: 28025944
[TBL] [Abstract][Full Text] [Related]
18. Focused Ultrasound Strategies for Brain Tumor Therapy.
Bunevicius A; McDannold NJ; Golby AJ
Oper Neurosurg (Hagerstown); 2020 Jul; 19(1):9-18. PubMed ID: 31853548
[TBL] [Abstract][Full Text] [Related]
19. Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB.
Zhu J; Zhang Y; Chen X; Zhang Y; Zhang K; Zheng H; Wei Y; Zheng H; Zhu J; Wu F; Piao JG; Zhu Z; Li F
Biochem Biophys Res Commun; 2021 Jan; 534():902-907. PubMed ID: 33162028
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.
Liu HL; Hua MY; Chen PY; Chu PC; Pan CH; Yang HW; Huang CY; Wang JJ; Yen TC; Wei KC
Radiology; 2010 May; 255(2):415-25. PubMed ID: 20413754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
